PMC:7696151 / 118495-118861 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7696151","sourcedb":"PMC","sourceid":"7696151","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7696151","text":"800 mg once, followed by 600 mg in 6 to 8 h, then 600 mgdaily for 4 additional daysPlacebo group The incidence of new illness compatible with Covid-19 did not differ significantly between the HCQ group (49 of 414 (11.8%)) and the placebo group (58 of 407 (14.3%)); the absolute difference was −2.4 percentage points (95% confidence interval, −7.0 to 2.2; p = 0.35).","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"4233","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A4233","pred":"tao:has_database_id","subj":"4233","obj":"MESH:C000657245"},{"subj":"4233","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T786","span":{"begin":0,"end":366},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T786","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ecd393","default":true},{"id":"LitCovid-sentences","color":"#b993ec"}]}]}}